Shares of Marksans Pharma rallied greater than 17% to ₹50 apiece on the BSE in Tuesday’s buying and selling session after the corporate knowledgeable its plans to contemplate the difficulty of bonus shares. Bonus shares are absolutely paid further shares issued by an organization to its present shareholders.
The corporate’s board will meet this week on Friday, July 8, 2022 to contemplate the proposal for bonus shares difficulty. “We want to inform you {that a} assembly of the Board of Administrators of the Firm is scheduled to be held on Friday, eighth July, 2022 to contemplate the proposal for buyback of absolutely paid up fairness shares of the Firm upto such quantity of the combination of Firm’s paid up fairness share capital and free reserves,” Marksans Pharma stated in an change submitting.
Marksans Pharma Ltd. is an Indian pharmaceutical firm having a world footprint in analysis, manufacturing and advertising and marketing of completed dosage pharmaceutical formulations. Marksans Pharma shares have declined greater than 45% in a yr’s interval, whereas the pharma inventory is down about 18% in 2022 (YTD) to date.
It’s additional knowledgeable that the buying and selling window for dealing within the shares of the corporate for the designated particular person(s) is already closed w.e.f. July 0 I, 2022 and can stay closed until 48 hours after the declaration of unaudited monetary outcomes for the quarter ended June 30, 2022, the corporate added.
Final month, the corporate knowledgeable that its board at its assembly held on thirtieth Could, 2022 at Mumbai, really useful remaining dividend @ Re. 0.25 (Rupee Zero and Paise Twenty 5) i.e. 25% per fairness share of Re. 1/- every face worth for the monetary yr ended thirty first March, 2022, topic to approval of the shareholders within the ensuing Annual Common Assembly (AGM). The E-book Closure/ Document Date for the Ultimate dividend shall be intimated sooner or later.